Difference between revisions of "Mark Fishman"
Jump to navigation
Jump to search
(Added: employment, alma_mater, interests.) |
(a bit short, but - unstub) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
|wikipedia=https://en.wikipedia.org/wiki/Mark_Fishman | |wikipedia=https://en.wikipedia.org/wiki/Mark_Fishman | ||
|amazon= | |amazon= | ||
| − | | | + | |description=Biotech researcher for [[Novartis]] who attended the [[2013 Bilderberg]]. |
|spartacus= | |spartacus= | ||
| − | + | |image=Mark Fishman.png | |
| − | |image= | + | |birth_date=1947 |
| − | |birth_date= | ||
|birth_place= | |birth_place= | ||
|death_date= | |death_date= | ||
|death_place= | |death_place= | ||
| + | |nationality=US | ||
|constitutes=researcher, businessman | |constitutes=researcher, businessman | ||
|alma_mater=Yale College, Harvard Medical School | |alma_mater=Yale College, Harvard Medical School | ||
|interests=Medicine | |interests=Medicine | ||
| − | |employment= | + | |employment={{job |
| + | |title=President of Novartis Institutes for BioMedical Research | ||
| + | |start=2002 | ||
| + | |end=2016 | ||
| + | |employer=Novartis | ||
| + | |description=Attended the [[2013 Bilderberg]] | ||
}} | }} | ||
| + | }} | ||
| + | '''Mark Fishman''' is an American cardiologist. A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR),<ref>https://web.archive.org/web/20150601033038/http://www.novartis.com/about-novartis/people/executive-committee.shtml</ref> the main research arm of [[Novartis|Novartis Pharmaceuticals]].<ref>https://web.archive.org/web/20110202150643/http://www.novartis.com/newsroom/fact-sheet.shtml</ref> | ||
| + | |||
| + | Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.<ref>https://web.archive.org/web/20110616200321/http://www.prdomain.com/companies/N/Novartis/newsreleases/20025718532.htm</ref> He is the author of over 100 publications<ref>http://www.pubmed.gov 183 results as of 20 Oct 2009</ref> and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.<ref>https://semanticscholar.org/paper/c906a31f1b1974e1740f26cd2939b5457fb7e162</ref><ref>[https://web.archive.org/web/20090403210634/http://people.forbes.com/profile/mark-c-fishman/58785 Forbes.com]</ref><ref>https://web.archive.org/web/20110725033719/http://www.baderc.org/bios/FishmanBios.pdf</ref> | ||
| + | |||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
| − | |||
Latest revision as of 00:09, 6 July 2022
 Mark Fishman    (researcher, businessman) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | ||||||||||||||
| Born | 1947 | |||||||||||||
| Nationality | US | |||||||||||||
| Alma mater | Yale College, Harvard Medical School | |||||||||||||
| Interests | Medicine | |||||||||||||
Biotech researcher for Novartis who attended the 2013 Bilderberg.
| ||||||||||||||
Mark Fishman is an American cardiologist. A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR),[1] the main research arm of Novartis Pharmaceuticals.[2]
Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.[3] He is the author of over 100 publications[4] and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.[5][6][7]
Events Participated in
| Event | Start | End | Location(s) | Description |
|---|---|---|---|---|
| Bilderberg/2013 | 6 June 2013 | 9 June 2013 | Watford UK | The 2013 Bilderberg group meeting. |
| WEF/Annual Meeting/2014 | 22 January 2014 | 25 January 2014 | World Economic Forum Switzerland | 2604 guests in Davos considered "Reshaping The World" |
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
References
- ↑ https://web.archive.org/web/20150601033038/http://www.novartis.com/about-novartis/people/executive-committee.shtml
- ↑ https://web.archive.org/web/20110202150643/http://www.novartis.com/newsroom/fact-sheet.shtml
- ↑ https://web.archive.org/web/20110616200321/http://www.prdomain.com/companies/N/Novartis/newsreleases/20025718532.htm
- ↑ http://www.pubmed.gov 183 results as of 20 Oct 2009
- ↑ https://semanticscholar.org/paper/c906a31f1b1974e1740f26cd2939b5457fb7e162
- ↑ Forbes.com
- ↑ https://web.archive.org/web/20110725033719/http://www.baderc.org/bios/FishmanBios.pdf
